Analytical Data
-
Gene name
nuc1
- Application
-
Species
Pandalus borealis
-
Source
E. coli
-
Tag
N- MBP
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
C9YSL6
-
Expression Region
25-404aa
-
Molecular Weight
83.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The NUC1 protein, a member of the nucleoside triphosphate (NTP) pyrophosphatase family, has garnered significant attention in the field of molecular biology due to its critical role in nucleotide metabolism and cellular stress responses. Research has shown that NUC1 is involved in various cellular processes, including the regulation of ATP levels, which are fundamental to energy homeostasis and signal transduction pathways. The recombinant production of NUC1 has facilitated detailed studies of its biochemical properties, functional mechanisms, and interactions with other cellular components. Given its importance in maintaining cellular viability and function, the study of NUC1 and its recombinant forms is essential for understanding its potential implications in disease states, particularly those related to cellular stress and metabolic dysregulation. Additionally, the exploration of NUC1 as a therapeutic target has opened new avenues for drug development aimed at diseases where nucleotide metabolism plays a pivotal role. Consequently, the investigation of NUC1 not only provides insights into fundamental biological processes but also holds promise for advancing therapeutic strategies in various pathologies.
